Molecular Targeting Technologies, Inc.
Molecular Targeting Technologies, Inc. is a small business in West Chester, PA registered on SAM.gov to bid on federal contracts. It has won 5 small business R&D awards worth $2.8 million through the SBIR and STTR programs since 2017, according to SBIR.gov.
- UEI
- Y2FNW7N1V267
- CAGE code
- 489G0
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Molecular Targeting Technologies, Inc. |
|---|---|
| Unique Entity ID (UEI) | Y2FNW7N1V267 |
| CAGE code | 489G0 |
| Location | West Chester, PA |
| SAM.gov registration | Active through Mar 2, 2027 |
| Business started | 2001 |
| Primary NAICS code | 325413: In-Vitro Diagnostic Substance Manufacturing |
| Website | www.mtarget.com |
Certifications and business types
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Molecular Targeting Technologies, Inc.. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Molecular Targeting Technologies, Inc. has won 5 small business R&D awards worth $2.8 million through the SBIR and STTR programs since 2017, 1 of them Phase II and 1 STTR. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Feb 1, 2023 | NIH | STTR Phase I Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk | $299,890 |
| Sep 1, 2022 | NIH | SBIR Phase II Instantaneous Tumor Spray for Real-Time Surgical Guidance | $2 million |
| Apr 9, 2018 | NIH | SBIR Phase I Sprayable, Prompt Color Changing Dye to Delineate Ovarian Cancer During Surgery | $253,411 |
| Aug 1, 2017 | NIH | SBIR Phase I Topical Drug Treatment of Cutaneous Leishmaniasis | $214,174 |
| 2018 | NIH | SBIR Phase I Topic 368: Biotherapy of Brain Tumors by Radioiodinated SapC-DOPS Nanovesicles | $50,007 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Molecular Targeting Technologies, Inc. is small under
On its SAM.gov registration, Molecular Targeting Technologies, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
Open contracts in Molecular Targeting Technologies, Inc.'s NAICS codes
18 open federal opportunities on SAM.gov use one of Molecular Targeting Technologies, Inc.'s NAICS codes and are open to it: no set-aside, or, in the codes it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first, then those in Pennsylvania, then the soonest due.
- Abbott Architect i1000 Reagents
✦ The VA's Network Contracting Office 22 is asking industry (a sources sought / RFI, not a solicitation) who can supply immunoassay reagents, consumables and supplies for the…
Due in 11 daysOct 22, 2026
- Cepheid GeneXpert Testing Supplies
✦ The VA's Network Contract Office 5 plans to buy Cepheid GeneXpert testing supplies for six VA medical centers in West Virginia, Maryland and Washington DC. It expects one…
Due in 36 daysNov 16, 2026
- Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC
✦ The VA's Network Contracting Office 20 is doing market research for rapid syndromic molecular testing reagents (lab test supplies) for the Puget Sound VA Medical Center, which…
Due Aug 6, 2027
- Lab Supplies - Radiopharm Philadelphia VA Medical Center
Due in 4 daysOct 15, 2026
- Prednisolone 1% Ophthalmic Solution
Due in 3 daysOct 14, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (325413) that have won federal contracts. None in Pennsylvania have yet, so these are in nearby states:
- Columbus Nanoworks, Inc., Columbus, OH
- Biopool U.S., Inc., Jamestown, NY
Frequently asked questions
What is Molecular Targeting Technologies, Inc.'s CAGE code?
Molecular Targeting Technologies, Inc.'s CAGE code is 489G0. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Molecular Targeting Technologies, Inc.'s UEI?
Molecular Targeting Technologies, Inc.'s Unique Entity ID (UEI) is Y2FNW7N1V267. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Molecular Targeting Technologies, Inc.'s SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Molecular Targeting Technologies, Inc.'s registration is active through Mar 2, 2027. Registrations are renewed every year.
Is Molecular Targeting Technologies, Inc. a small business?
Molecular Targeting Technologies, Inc. is registered on SAM.gov as small under 3 NAICS codes, including its primary code, 325413. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.